Peptide dose, MHC affinity, and target self-antigen expression are critical for effective immunotherapy of nonobese diabetic mouse prediabetes

Journal of Immunology

Volumn 165, Issue 7, 2000, Pages 4086-4094

  Winer, S ^a   Gunaratnam, L ^a   Astsatourov, I ^a   Cheung, R K ^a   Kubiak, V ^a   Karges, W ^a   Hammond Mckibben, D ^a   Gaedigk, R ^a   Graziano, D ^a   Trucco, M ^a   Becker, D J ^a   Dosch, H M ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ABBOS ANTIGEN; AUTOANTIGEN; CYCLOPHOSPHAMIDE; EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE ANTIGEN; TEP69 ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; IMMUNOTHERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL;

EID: 0034292430     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.7.4086     Document Type: Article

References (65)

1. T helper cell subsets in insulin-dependent diabetes
2. Initiation of autoimmune diabetes in NOD/Lt mice is MHC class I-dependent
3. Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library
4. Self and non-self antigen in diabetic autoimmunity: Molecules and mechanisms
5. The NOD mouse model of type l diabetes: As good as it gets?
6. Genetic control of diabetes progression
7. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice
8. Identification and mapping to chromosome I of a susceptibility locus for periinsulitis in non-obese diabetic mice
9. Ontogeny of islet cell antibodies, insulin autoantibodies and insulitis in the non-obese diabetic mouse
10. β-cell destruction may be a late consequence of the autoimmune process in nonobese diabetic mice
11. Prevention of type I diabetes: Is now the time?
12. Comparative genetics of type I diabetes and autoimmune disease: Common loci, common pathways?
13. Genetic control of autoimmune diabetes in the NOD mouse
14. Aspartic acid at position 57 of the HLA-DQ beta chain protects against type I diabetes: A family study
15. g7β-chain diminishes the spontaneous incidence of insulin-dependent diabetes mellitus
16. Worldwide differences in the incidence of type I diabetes are associated with amino acid variation at position 57 of the HLA-DQ β chain
17. g7 molecules from non-obese diabetic mice are poor peptide binders
18. HLA-DR binding analysis of peptides from islet antigens in IDDM
19. Exceptional stability of the HLA-DQA1*0102/DQB1*0602 αβ protein dimer, the class II MHC molecule associated with protection from insulin-dependent diabetes mellitus
20. Quantitative thresholds of MHC class II I-E expressed on hemopoietically derived antigen-presenting cells in transgenic NOD/Lt mice determine level of diabetes resistance and indicate mechanism of protection
21. An Abd transgene prevents diabetes in nonobese diabetic mice by inducing regulatory T cells
22. MHC class II Ab diabetogenic residue 57 Asp/non-Asp dimorphism influences T-cell recognition and selection
23. Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients: Identity of key contact residues in the B-cell and T-cell epitopes
24. Diabetes induced by coxsackie virus: Initiation by bystander damage and not mimicry
25. T cell responses to enterovirus antigens and to β-cell autoantigens in unaffected children positive for IDDM-associated autoantibodies
26. Immunological aspects of nutritional diabetes prevention in NOD mice: A pilot study for the cow's milk-based IDDM prevention trial
27. Putative environmental factors in type 1 diabetes
28. IDDM prevention trials in progress: A critical assessment
29. A bovine albumin peptide as a possible trigger of insulin dependent diabetes mellitus
30. Humoral immune response to bovine serum albumin in new onset and established insulin-dependent diabetes mellitus
31. Antibodies to bovine serum albumin in Brazilian children and young adults with IDDM
32. T cell activation and anergy to islet cell antigen in type 1 diabetes
33. Significance of cow's milk protein antibodies as risk factor for childhood IDDM: Interactions with dietary cow's milk intake and HLA-DQB1 genotype
34. Loss of self-tolerance to ICA69 in non-obese diabetic mice
35. Persistent T cell anergy in human type 1 diabetes
36. Genomic organization of human and mouse ICAp69, a target antigen in diabetic autoimmunity
37. B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: Analysis of a new "speed congenic" stock of NOD.Ig γ null mice
38. Molecular cloning of murine ICA69: Diabetes-prone mice recognize the human autoimmune-epitope, Tep69, conserved in splice variants from both species
39. Cellular toxicity of sulfamethoxazole reactive metabolites. II. Inhibition of natural killer activity in human peripheral blood mononuclear cells
40. Fluorescence-based viability assay for studies of reactive drug intermediates
41. The β-chains of DP4 molecules from different haplotypes are encoded by the same gene
42. A peptide-binding motif for I-A(g7), the class II major histocompatibility complex (MHC) molecule of NOD and Biozzi AB/H mice
43. Promotion of spontaneous diabetes in nonobese diabetic-prone mice by cyclophosphamide
44. Induction of glutamic acid decarboxylase 65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease is epitope dependent
45. Immunization of non-obese diabetic (NOD) mice with glutamic acid decarboxylase-derived peptide 524-543 reduces cyclophosphamide-accelerated diabetes
46. Endogenous immune response to glutamic acid decarboxylase (GAD67) in NOD mice is modulated by adjuvant immunotherapy
47. 4+ T cells protect from autoimmune diabetes via bystander suppression using the IL4/Stat6 pathway
48. Retardation or acceleration of diabetes in NOD/Lt mice mediated by intrathymic administration of candidate β-cell antigens
49. Glutamate decarboxylase and GABA in pancreatic islets: Lessons from knock-out mice
50. The efficiency of CD4 recruitment to ligand-engaged TCR controls the agonist/partial agonist properties of peptide-MHC molecule ligands
51. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo
52. Chronic intravenous injections of antigen induce and maintain tolerance in T cell receptor-transgenic mice
53. Late complications of immune deviation therapy in a non-human primate
54. Potential risk of oral insulin with adjuvant for the prevention of type I diabetes: A protocol effective in NOD mice exacerbates disease in BB rats
55. Induction of autoimmune diabetes by oral administration of autoantigen
56. Induction and suppression of an autoimmune disease by oligomerized T cell epitopes, enhanced in vivo potency of encephalitogenic peptides
57. BCG vaccination prevents insulin-dependent diabetes mellitus (IDDM) in NOD mice after disease acceleration with cyclophosphamide
58. Differences between responses of naive and activated T cells to anergy induction
59. Gene expression of islet cell antigen p69 (ICAp69) in man, mouse and rat
60. Self-reactive T cells selected on thymic cortical epithelium are polyclonal and are pathogenic in vivo
61. Incomplete elimination of the ABBOS epitope of bovine serum albumin under simulated gastrointestinal conditions of infants
62. Chlamydia infections and heart disease linked through antigenic mimicry
63. A viral peptide with limited homology to a self peptide can induce clinical signs of experimental autoimmune encephalomyelitis
64. Cow milk, BSA and IDDM: Can we settle the controversies?
65. Dietary cow's milk protein does not alter the frequency of diabetes in the BB rat